Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery

NCT01053897 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Scar Formation

Interventions

BIOLOGICAL: GBT009
BIOLOGICAL: Placebo

Sponsor

Garnet BioTherapeutics, Inc.